Trials / Active Not Recruiting
Active Not RecruitingNCT06976996
Efficacy of Esketamine Combined With Different General Anesthetics on Quality of Postoperative Recovery
Efficacy of Subanesthetic Dose of Esketamine Combined With Different General Anesthetics on Quality of Early Postoperative Recovery in Patients Undergoing Painless Gastrointestinal Endoscopy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 190 (estimated)
- Sponsor
- Northern Jiangsu People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To explore the effect of subanesthetic-dose esketamine combined with different general anesthetic drugs on the quality of postoperative recovery in patients undergoing painless gastrointestinal endoscopy.
Detailed description
In this study, we planned to conduct a single-center, prospective, randomized, controlled, double-blind clinical trial to explore the effect of subanesthetic dose esketamine combined with different general anesthesia drugs on the postoperative recovery quality of patients undergoing painless gastrointestinal endoscopy combined with several commonly used intravenous general anesthesia drugs, aiming at gastroscopy combined with colonoscopy, a representative type of diagnosis and treatment of painless and comfortable anesthesia, and to provide more evidence-based medical evidence for clinical work.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | normal saline | normal saline (0.15 ml/kg) |
| DRUG | esketamine | esketamine (0.15 mg/kg) |
| DRUG | propofol | propofol (2 mg/kg) |
| DRUG | etomidate-ciprofol (EC) mixture | etomidate-ciprofol (EC) mixture (0.2 ml/kg) |
| DRUG | ciprofol | ciprofol (0.5 mg/kg) |
| DRUG | etomidate-propofol (EP) mixture | etomidate-propofol (EP) mixture (0.2 ml/kg) |
Timeline
- Start date
- 2025-03-16
- Primary completion
- 2025-12-15
- Completion
- 2025-12-15
- First posted
- 2025-05-16
- Last updated
- 2025-05-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06976996. Inclusion in this directory is not an endorsement.